In this article, Thermo Scientific Visualization Data Solutions discusses how a study using Amira software can help explain why we lose muscle mass as we age.
Pharming is paying $66.1 million to acquire Swedish biotech Abliva and its phase 2-stage med that the Dutch drugmaker believes has blockbuster potential with a type of mitochondrial disease.